Biostage, Inc. entered into securities purchase agreements with certain investors in a private placement an aggregate of 1,000,967 common shares at a price of $6 per share for the gross proceeds of $6.005802 million on March 31, 2023.
Harvard Apparatus Regenerative Technology Inc.
Equities
HRGN
US09074M2026
Advanced Medical Equipment & Technology
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
2.63 USD | -0.38% | +4.37% | -47.29% |
1st Jan change | Capi. | |
---|---|---|
-47.29% | 37.65M | |
+7.77% | 218B | |
+10.16% | 189B | |
+26.21% | 151B | |
+32.78% | 113B | |
+1.98% | 64.02B | |
+14.48% | 52.6B | |
+2.92% | 49.85B | |
-6.60% | 37.89B | |
-1.07% | 34.92B |
- Stock Market
- Equities
- HRGN Stock
- News Harvard Apparatus Regenerative Technology Inc.
- Biostage, Inc. announced that it expects to receive $6.005802 million in funding